Soluble amyloid precursor proteins and secretases as Alzheimer's disease biomarkers

被引：35
|
作者：
Perneczky, Robert [1 ,2 ,3 ]
Alexopoulos, Panagiotis [3 ]
Kurz, Alexander [3 ]
机构：
[1] Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London W6 8RP, England
[2] West London Mental Hlth Trust, West London Cognit Disorders Treatment & Res Unit, London TW8 8DS, England
[3] Tech Univ Munich, Dept Psychiat & Psychotherapy, D-81675 Munich, Germany
来源：
TRENDS IN MOLECULAR MEDICINE | 2014年 / 20卷 / 01期
关键词：
biomarker; amyloid precursor protein; Alzheimer's disease; dementia; secretase; early diagnosis; MILD COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID BIOMARKERS; SORTILIN-RELATED RECEPTOR; BETA-SECRETASE; ALPHA-SECRETASE; BACE1; ACTIVITY; NATIONAL INSTITUTE; CLEAVING ENZYME; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES;
D O I：
10.1016/j.molmed.2013.10.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Recently revised diagnostic guidelines for Alzheimer's disease (AD) emphasise the use of biomarkers, heralding a paradigm shift towards a more biological definition of the disorder. Currently available biomarkers offer added diagnostic accuracy in certain situations, but their performance in terms of early diagnostic sensitivity and specificity does not fully live up to the desired standards. One feasible approach to improve the diagnostic and prognostic performance of AD biomarkers is to measure upstream events of amyloid precursor protein (APP) processing, which are at the core of the initial phase of AD pathogenesis. Here we review evidence on the APP processing enzymes and their cleavage products and discuss possible applications and limitations in their use as AD biomarkers.
引用
收藏
页码：8 / 15
页数：8
相关论文
共 50 条
  • [31] Transmembrane amyloid-related proteins in CSF as potential biomarkers for Alzheimer's disease
    Lopez-Font, Inmaculada
    Cuchillo-Ibanez, Inmaculada
    Sogorb-Esteve, Aitana
    Garcia-Ayllon, Maria-Salud
    Saez-Valero, Javier
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [32] On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor
    Robakis, Nikolaos K.
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (01) : 3 - 4
  • [33] Amyloid precursor protein mRNAs in Alzheimer's disease
    Harrison, PJ
    WightonBenn, WH
    Heffernan, JM
    Sanders, MW
    Pearson, RCA
    NEURODEGENERATION, 1996, 5 (04): : 409 - 415
  • [34] Amyloid Precursor Protein Processing in Alzheimer's Disease
    Bhadbhade, Adwait
    Cheng, Davis Weizhong
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2012, 6 (01) : 1 - 4
  • [35] Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
    Julia, T. C. W.
    Goate, Alison M.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (06):
  • [36] Amyloid precursor protein, copper and Alzheimer's disease
    Multhaup, G
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (03) : 105 - 111
  • [37] The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
    Storey, E
    Cappai, R
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1999, 25 (02) : 81 - 97
  • [38] The amyloid peptide and its precursor in Alzheimer's disease
    Octave, JN
    REVIEWS IN THE NEUROSCIENCES, 1995, 6 (04) : 287 - 316
  • [39] Alzheimer's disease: a dysfunction of the amyloid precursor protein
    Neve, RL
    McPhie, DL
    Chen, YH
    BRAIN RESEARCH, 2000, 886 (1-2) : 54 - 66
  • [40] Amyloid Precursor Protein Processing and Alzheimer's Disease
    O'Brien, Richard J.
    Wong, Philip C.
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 34, 2011, 34 : 185 - 204
12345